Polycystic ovarian syndrome indiscriminately strikes women between the ages of puberty and menopause. It is the leading cause of female infertility, and if left untreated can lead to obesity, diabetes, heart disease, and endometrial cancer. Although metformin therapy have been some beneficial effects in PCOS patient, further investigation and controlled studies are necessary to evaluate long-term effect. A number of reports show that Chinese herbs improve menstrual function, however, only few studies have been placebo-controlled. The aim of our study was to use a double blind, placebo-controlled, approach with assessment of menstrual function and BMI reduction. All of 72 Chinese women with obese polycystic ovary syndrome (PCOS) were randomized to receive Gui-zhi-fu-ling-wan and Auricularia polytricha Formula or placebo with l5g three times daily for 6 months. Anthropometric, endocrine, and ovarian ultrasound assessments were effected before and after 6 months treatment. Gui-zhi-fu-ling-wan and Auricularia polytricha Formula treatment, resulted in a significant decrease in Menstrual index, BMI, body weight, and Testosterone (p<0.0001), as well as also decrease in triglycerides, and low-density lipoprotein (LDL). Gui-zhi-fu-ling-wan and Auricularia polytricha Formula is well tolerated by the majority of patients and may be clinically useful as an alternative treatment for metformin, particularly in patients having obese PCOS and menstrual disturbances.
Polycystic ovarian syndrome indiscriminately strikes women between the ages of puberty and menopause. It is the leading cause of female infertility, and if left untreated can lead to obesity, diabetes, heart disease, and endometrial cancer. Although metformin therapy have been some beneficial effects in PCOS patient, further investigation and controlled studies are necessary to evaluate long-term effect. A number of reports show that Chinese herbs improve menstrual function, however, only few studies have been placebo-controlled. The aim of our study was to use a double blind, placebo-controlled, approach with assessment of menstrual function and BMI reduction. All of 72 Chinese women with obese polycystic ovary syndrome (PCOS) were randomized to receive Gui-zhi-fu-ling-wan and Auricularia polytricha Formula or placebo with l5g three times daily for 6 months. Anthropometric, endocrine, and ovarian ultrasound assessments were effected before and after 6 months treatment. Gui-zhi-fu-ling-wan and Auricularia polytricha Formula treatment, resulted in a significant decrease in Menstrual index, BMI, body weight, and Testosterone (p<0.0001), as well as also decrease in triglycerides, and low-density lipoprotein (LDL). Gui-zhi-fu-ling-wan and Auricularia polytricha Formula is well tolerated by the majority of patients and may be clinically useful as an alternative treatment for metformin, particularly in patients having obese PCOS and menstrual disturbances.